Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Aldosterone and Residual Cardiorenal Risk: Pathophysiology and Emerging Therapeutic Strategies.

This review distinguishes aldosterone excess from MR activation and proposes a nephrology-focused clinical framework separating established MRA indications, evaluation for primary aldosteronism, and the unestablished cardiorenal outcome role of aldosterone synthase inhibitors (ASIs).

M. Kanbay, Rama Al-Shiab, Ermeena Shah et al. · 0 citations
Review Open access Sep 2026

Ten tips to reduce fracture risk by non-pharmacologic interventions in CKD-associated osteoporosis

10 tips for non-pharmacological interventions with the potential to modify fracture risk in CKD patients are described, which are often applicable to patients with CKD without restrictions, with some specific considerations in end-stage kidney disease.

D. Hansen, Hanne Skou-Jørgensen, M. Kanbay et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.